News
Genoskin invited to MEDEF meeting on how CEOs can drive change
Every year, the MEDEF, France’s largest entrepreneurial organisation, sets up local conferences in an attempt to bring companies together under a predefined theme. This year, Genoskin was invited to the 7th Edition of the Entrepreneurial Event (Grande Tribune des Entrepreneurs) to contribute to the discussion on the role of CEOs in driving change. The widely attended conference was headed by Pierre Gataz, the MEDEF’s president (see
CEO Innovation Award
On March 9th, 2017, Genoskin won the Award for Innovation at the CEO Company Challenge meeting in Colomiers, France. The award highlights local companies that have special merit in the area of export, innovation and job creation. Genoskin wins CEO Award for Innovation In the light of today’s challenging economic context, the CEO West-Toulouse Company Club aims to highlight the driving efforts of
US Patent for human skin models
Genoskin obtains US patent for skin models Genoskin is pleased to announce the approval of a US patent for our “system for the maintenance and survival of skin biopsies in transport and its applications”. The patent describes our method to transform human skin biopsies in ready-to-use and functional ex vivo skin models. The human skin biopsies that are used in our models
Genoskin finalist of Start-Up Connexion 2017
On February 3, 2017, Genoskin was awarded a finalist spot in the third edition of the Start-up Connexion Contest. This event brings together innovative research companies and potential investors to highlight and finance projects with high economic value. The Start-up Connexion Contest is a combined initiative of the CNRS (French National Center for Scientific Research) and the AEF Media Group, which specializes in
ISO9001 certification
Genoskin obtains ISO9001 certification The entire Genoskin team is proud to announce that we obtained the ISO9001:2015 certification in January 2017. This certificate validates the quality and consistency of our design and R&D services as well as the commercialization of human skin models, cells and tissues to pharmaceutical, chemical and cosmetic industries. Consistent quality for skin models and R&D programs The
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
